Chronic pulmonary function impairment caused by initial and recurrent pulmonary tuberculosis following treatment

Thorax

Volumn 55, Issue 1, 2000, Pages 32-38

  Hnizdo, Eva ^a   Singh, Tanusha ^a   Churchyard, Gavin ^b  

^a National Centre for Occupational Health   (South Africa)

^b AngloGold Ashanti Limited   (South Africa)

Author keywords

Chronic lung function impairment; Silica dust; Tuberculosis

Indexed keywords

ADULT; AIRWAY OBSTRUCTION; ARTICLE; CHRONIC LUNG DISEASE; CONTROLLED STUDY; DRUG THERAPY; FORCED EXPIRATORY VOLUME; HIGH RISK PATIENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MINER; PRIORITY JOURNAL; RECURRENT DISEASE; RETROSPECTIVE STUDY; SOUTH AFRICA; VITAL CAPACITY;

ADULT; AIRWAY OBSTRUCTION; CHRONIC DISEASE; FORCED EXPIRATORY VOLUME; HIV INFECTIONS; HUMANS; MIDDLE AGED; MINING; OCCUPATIONAL DISEASES; RECURRENCE; RETROSPECTIVE STUDIES; RISK FACTORS; SOUTH AFRICA; TUBERCULOSIS, PULMONARY; VITAL CAPACITY;

EID: 0034013823     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thorax.55.1.32     Document Type: Article

References (20)

1. 1 Snider GL, Doctor L, Demas TA, et al. Obstructive airways disease in patients with treated pulmonary tuberculosis. Am Rev Respir Dis 1971;103:625-40.
2. 2 Birath G, Caro J, Malmbere R, et al. Airways obstruction in pulmonary tuberculosis. Scand J Respir Dis 1966;47:27-36.
3. 3 Lancaster JF, Tomashefski JF. Tuberculosis: a cause of emphysema. Am Rev Respir Dis 1963;87:435-7.
4. 4 Simpson DG, Kuschner M, McClement J. Respiratory function in pulmonary tuberculosis. Am Rev Respir Dis 1963;87:1-16.
5. 5 Plit ML, Anderson R, Van Rensburg CEJ, et al. Influence of antimicrobial chemotherapy on spirometric parameters and pro-inflammatory indices in severe pulmonary tuberculosis. Eur Respir J 1998;12:351-6.
6. 6 Willcox PA, Ferguson AD. Chronic obstructive airways disease following treated pulmonary tuberculosis. Respir Med 1989;83:195-8.
7. 7 Krishna K, Bond S, Artvinli M, et al. Pulmonary function in treated tuberculosis; a long term follow-up. Am Rev Respir Dis 1977;115:402.
8. 8 Vargha G. Fifteen year follow-up of lung function on obstructive and non-obstructive pulmonary tuberculosis. Acta Med Hung 1983;40:271-6
9. 9 Kleinschmidt I, Churchyard G. Variation in incidence of tuberculosis in subgroups of South African gold miners. Occup Environ Med 1997;54:636-41.
10. 10 Hnizdo E, Murray J. Risk of pulmonary tuberculosis relative to silicosis and exposure to silica dust in South African gold miners. Occup Environ Med 1998;55:496-502.
11. 11 Cowie RL. The epidemiology of tuberculosis in gold miners with silicosis. Am J Respir Crit Care Med 1994;150:1460-2.
12. 12 Murray J, Kielkowski D, Reid P. Occupational disease trends in black South African gold miners. Am J Respir Crit Care Mad 1996;153:706-10.
13. 13 Corbett EL, Churchyard GJ, Moyake T, et al. HIV infection, silicosis and mycobacterial disease incidence in South African miners. Int J Tuberc Lung Dis 1998;2:S301.
14. 14 Escreet BC, Langton ME, Cowie RL. Short-course chemotherapy for silicotuberculosis. S Afr Med J 1984; 68:327-30.
15. 15 Hnizdo E, Churchyard G, Barnes D, et al. Assessment of reliability of lung function screening program. Am J Respir Crit Care Med 1999 (in press).
16. 16 Louw SJ, Goldin JG, Joubert G. Spirometry of healthy adult South African men. S Afr Med J 1996;86:814-9.
17. 17 Snedecor GW, Cochran WG. Statistical methods. Iowa: The Iowa State University Press, 1968.
18. 18 Jung-Gi Im, Harumi Iton, Kyung Soo Lee, et al. CT-pathology correlation of pulmonary tuberculosis. Crit Rev Diagn Imaging 1995;36:227-85.
19. 19 Cowie RL, Mabena SK. Silicosis, chronic airflow limitation and chronci bronchitis in South African gold miners. Am Rev Respir Dis 1991;143:80-4.
20. 20 Hnizdo E, Hessel PA, Sluis-Cremer GK. Chronic airflow limitation in South African gold miners. Am Rev Respir Dis 1991;148:1423.